NCT02737566

Brief Summary

The primary objectives of this study are 1) to evaluate the longer-term impact of an adjunctive, low-cost financial incentives intervention (relative to standard care) on smoking abstinence rates among socioeconomically disadvantaged individuals participating in a clinic-based smoking cessation program and 2) to identify treatment mechanisms and contextual factors associated with cessation outcomes among intervention participants using both traditional and ecological momentary assessment approaches. Those randomized to the financial incentives intervention will have the opportunity to earn small gift cards for biochemically-verified abstinence through 12 weeks post-quit. We hypothesize that individuals who are randomly assigned to the adjunctive CM intervention will have significantly higher rates of biochemically-verified abstinence at the 26-week post-quit follow-up than those assigned to Usual Care. In addition, we hypothesize that several factors related to socioeconomic disadvantage will be directly associated with non-abstinence, especially greater stress/adversity, limited psychosocial resources, greater negative affect, greater nicotine dependence, and poorer treatment adherence. The primary study endpoints will include self-reported tobacco use/abstinence, expired carbon monoxide (CO) levels (i.e., the amount of carbon monoxide present in an individual's breath when they breathe out), and saliva cotinine levels at 26 weeks post-quit attempt, though smoking status will be assessed at all visits. Traditional questionnaire measurement and ecological momentary assessment (EMA) will be utilized to measure potential treatment mechanisms including motivation, self-efficacy, and treatment adherence. Other variables including stress/adversity, psychosocial resources, negative affect, nicotine dependence, and treatment adherence will also be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 7, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 14, 2016

Completed
10 months until next milestone

Study Start

First participant enrolled

January 30, 2017

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 8, 2022

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

April 20, 2023

Completed
Last Updated

May 13, 2026

Status Verified

April 1, 2026

Enrollment Period

5 years

First QC Date

April 7, 2016

Results QC Date

March 28, 2023

Last Update Submit

April 30, 2026

Conditions

Keywords

Smoking CessationFinancial IncentivesContingency ManagementVulnerable PopulationsMedically UninsuredMedicaid

Outcome Measures

Primary Outcomes (1)

  • Biochemically-verified Smoking Cessation

    The primary outcome measure is carbon monoxide (CO)-verified 7-day point prevalence abstinence at 26 weeks post-quit (intent-to-treat; missing=smoking).

    26 weeks post-quit

Secondary Outcomes (1)

  • Biochemically-verified Smoking Cessation

    12 weeks post-quit

Study Arms (2)

Standard Care + Financial Incentives

EXPERIMENTAL

Participants randomized to Standard Care + Financial Incentives for Abstinence will be offered smoking cessation counseling and pharmacotherapy (standard care) and they will have the opportunity to earn small gift cards for biochemically-verified abstinence through 12 weeks post-quit. The amount of the gift cards will escalate each week from the quit date through 4 weeks post-quit with continuous abstinence. Participants who are non-abstinent at any visit may earn incentives for abstinence at the next visit, but the amount will reset to the starting level. Participants may additionally earn an additional gift card for abstinence at the 8 and 12 weeks post-quit visits.

Behavioral: Standard Care + Financial Incentives

Standard Care

ACTIVE COMPARATOR

Participants randomized to Standard Care will be offered weekly smoking cessation counseling and pharmacotherapy.

Other: Standard Care

Interventions

Tobacco cessation counseling plus pharmacotherapy and financial incentives for quitting.

Standard Care + Financial Incentives

Tobacco cessation counseling plus pharmacotherapy.

Standard Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • are currently uninsured or receiving Medicaid benefits
  • earn a score ≥ 4 on the REALM indicating \> 6th grade English literacy level
  • are willing to quit smoking 7 days from their first visit
  • are ≥ 18 years of age
  • have an expired CO level ≥ 8 ppm suggestive of current smoking
  • are currently smoking ≥ 5 cigarettes per day
  • are willing and able to attend 9 study visits.

You may not qualify if:

  • are unwilling to quit smoking 7 days from their first visit
  • have already quit smoking
  • earn a score \<4 on the REALM indicating \< 7th grade literacy level
  • produce an expired CO level \< 8 ppm
  • are currently smoking \< 5 cigarettes per day
  • are unwilling or unable to attend study visits
  • are \< 18 years of age
  • are not uninsured or receiving Medicaid benefits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

TSET Health Promotion Research Center

Oklahoma City, Oklahoma, 73104, United States

Location

Related Publications (3)

  • Liang M, Koslovsky MD, Hebert ET, Kendzor DE, Businelle MS, Vannucci M. Bayesian continuous-time hidden Markov models with covariate selection for intensive longitudinal data with measurement error. Psychol Methods. 2023 Aug;28(4):880-894. doi: 10.1037/met0000433. Epub 2021 Dec 20.

  • Kendzor DE, Businelle MS, Frank-Pearce SG, Waring JJC, Chen S, Hebert ET, Swartz MD, Alexander AC, Sifat MS, Boozary LK, Wetter DW. Financial Incentives for Smoking Cessation Among Socioeconomically Disadvantaged Adults: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jul 1;7(7):e2418821. doi: 10.1001/jamanetworkopen.2024.18821.

  • Boozary LK, Chen M, Frank-Pearce SG, Hebert ET, Chen S, Alexander AC, Ogunsanya ME, Sifat MS, Oliver JA, Businelle MS, Kendzor DE. Discrimination experiences are associated with same-day and next-day smoking among adults with low socio-economic status trying to quit: A secondary analysis of data from a randomized clinical trial. Addiction. 2026 Apr 30. doi: 10.1111/add.70419. Online ahead of print.

MeSH Terms

Conditions

Smoking Cessation

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Limitations and Caveats

Study enrollment occurred from 2017-2021. As a result, a total of 146 (45.6%) of participants received treatment and/or had scheduled study assessments following the onset of the COVID-19 pandemic (in March 2020). The pandemic may have affected smoking cessation outcomes and other study variables, including retention and study follow-up rates through a variety of influences (e.g., institutional restrictions on research, financial, stress/mental health).

Results Point of Contact

Title
Dr. Darla Kendzor
Organization
The University of Oklahoma Health Sciences Center

Study Officials

  • Darla E. Kendzor, Ph.D.

    University of Oklahoma Health Campus

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2016

First Posted

April 14, 2016

Study Start

January 30, 2017

Primary Completion

February 8, 2022

Study Completion

February 8, 2022

Last Updated

May 13, 2026

Results First Posted

April 20, 2023

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations